Skip to content
OpenCapital
Get started

AtriCure ATRC Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$1.41B+48.1%
ITG
Integer HoldingsITGR
$4.4B-19.6%

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%—

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Calculated from AtriCure’s reported figures.

$1.4Bmarket cap+$76.2Mtotal debt−$146.2Mcash and equivalents=$1.35B

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's enterprise value?
AtriCure (ATRC) reported enterprise value of $1.35B in Q1 2026.
How has AtriCure's enterprise value changed year-over-year?
AtriCure's enterprise value decreased by 13.1% year-over-year, from $1.56B to $1.35B.
What is the long-term trend for AtriCure's enterprise value?
Over 5 years (2020 to 2025), AtriCure's enterprise value has grown at a -6.2% compound annual growth rate (CAGR), from $2.59B to $1.88B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.